Name of the Procedure:

Common Name: Shingrix vaccine administration
Medical Term: Zoster Vaccine Recombinant, Adjuvanted (Shingrix)

Summary

The Shingrix vaccine is a shot that helps prevent shingles, a painful skin rash caused by the varicella-zoster virus. It is typically given as two doses, separated by 2 to 6 months.

Purpose

The Shingrix vaccine is intended to prevent shingles and its complications, such as postherpetic neuralgia (PHN). The main goal is to reduce the incidence of shingles, alleviate the associated pain, and minimize the risk of long-term nerve damage.

Indications

• Adults aged 50 years and older.
• Adults 19 years and older who have weakened immune systems.
• Individuals who have had shingles previously.
• Those who have received another shingles vaccine (e.g., Zostavax) and need a more effective option.

Preparation

• No specific fasting or medication adjustments are typically required.
• Discuss with your healthcare provider if you have allergies, a weakened immune system, or other chronic conditions.
• Be prepared to receive two doses, 2 to 6 months apart.

Procedure Description

1. The healthcare provider cleans the injection site, usually the upper arm.
2. The vaccine is injected intramuscularly using a sterile syringe and needle.
3. Post-injection, the area is observed for a few minutes for any immediate adverse reactions.

Tools and Equipment

• Sterile syringe and needle.
• Shingrix vaccine.
• Alcohol swabs and band-aids.

Anesthesia or Sedation

• Not required.

Duration

The actual injection takes only a few minutes, but the entire visit may take about 15-30 minutes.

Setting

Typically administered in:

• Outpatient clinics.
• Doctor’s offices.
• Pharmacies.

Personnel

• Registered nurse.
• Medical assistant.
• Physician or licensed healthcare provider.

Risks and Complications

Common Risks:

• Pain, redness, or swelling at the injection site.
• Muscle ache or fatigue.
• Mild fever or headache.

Rare Risks:

• Allergic reactions, such as anaphylaxis.
• Severe pain or swelling lasting more than a few days.
• Guillain-Barré syndrome (extremely rare).

Benefits

• Reduced risk of developing shingles.
• Lower likelihood of experiencing complications like postherpetic neuralgia.
• Significant protection within just a few weeks after the second dose.

Recovery

• Mild side effects like soreness and fatigue are common and typically resolve in a few days.
• No significant downtime is expected.
• Follow-up with a second dose as scheduled.

Alternatives

• Zostavax, another shingles vaccine, though less effective.
• Choosing not to get vaccinated and relying on natural immunity, which is not recommended because of the high risk of complications.

Pros and Cons of Alternatives

• Zostavax: Fewer injections but lower efficacy.
• No vaccination: Risk of severe shingles and complications.

Patient Experience

During the procedure:

• Minor discomfort or pain at the injection site.
• Quick and straightforward process.

After the procedure:

• Possible soreness or redness at the injection site.
• Mild symptoms like fatigue or muscle aches can be managed with over-the-counter pain relievers, hydration, and rest.